BAYAU Bayview Acquisition Corporation

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File Number 001-41890

 

BAYVIEW ACQUISITION CORP

(Exact name of registrant as specified in its charter)

 

Cayman Islands		N/A
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

 

420 Lexington Ave, Suite 2446

New York, NY 10170

(Address of principal executive offices and zip code)

 

(347) 627-0058

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class		Trading Symbols		Name of Each Exchange on Which Registered
Units, each consisting of one ordinary share and one right		BAYAU		The Nasdaq Stock Market LLC
Common stock, par value $0.0001 per share		BAYA		The Nasdaq Stock Market LLC
Rights, each right entitling the holder thereof to one-tenth of one ordinary share		BAYAR		The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

As of May 15, 2024, there were 7,732,500 ordinary shares, par value $0.0001 issued and outstanding.

 

 

 

BAYVIEW ACQUISITION CORP

TABLE OF CONTENTS

 

		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023	1
	Unaudited Statements of Operations for the Three months ended March 31, 2024 and for the period from February 16, 2023 (inception) through March 31, 2023	2
	Unaudited Statements of Changes in Shareholders’ Deficit (Equity) for the Three months ended March 31, 2024 and for the period from February 16, 2023 (inception) through March 31, 2023	3
	Unaudited Statements of Cash Flows for the Three months ended March 31, 2024 and for the period from February 16, 2023 (inception) through March 31, 2023	4
	Notes to Unaudited Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	15
Item 4.	Controls and Procedures	15
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	16
Item 1A.	Risk Factors	16
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities	16
Item 3.	Defaults Upon Senior Securities	17
Item 4.	Mine Safety Disclosures	17
Item 5.	Other Information	17
Item 6.	Exhibits	17

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

BAYVIEW ACQUISITION CORP

BALANCE SHEETS

 

		March 31, 2024				December 31, 2023
		(Unaudited)
ASSETS
Current assets:
Cash		$	331,872			$	582,308
Other receivables (Note 6)			199,677				-
Prepaid expenses			132,500				72,014
Total current assets			664,049				654,322
Prepaid expenses – non-current			13,310				29,677
Investment held in trust account			60,861,367				60,107,055
Total Assets		$	61,538,726			$	60,791,054
LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accrued offering costs and expenses		$	466,055			$	303,759
Due to related party			-				10,000
Total Current Liabilities			466,055				313,759
Deferred underwriting commission payable			2,100,000				2,100,000
Total Liabilities			2,566,055				2,413,759
Commitments and contingencies			-				-
Ordinary shares subject to possible redemption (6,000,000 shares at redemption value of $10.14 and $10.02 as of March 31, 2024 and December 31, 2023, respectively)			60,861,367				60,107,055
Shareholders’ Deficit:
Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding			-				-
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,732,500 and 1,957,500 shares issued and outstanding (excluding 6,000,000 shares subject to possible redemption) at March 31, 2024 and December 31, 2023, respectively			173				196
Additional paid-in capital			-				-
Accumulated deficit			(1,888,869	)			(1,729,956	)
Total Shareholders’ Deficit			(1,888,696	)			(1,729,760	)
Total Liabilities and Shareholders’ Deficit		$	61,538,726			$	60,791,054

 

The accompanying notes are an integral part of these unaudited financial statement.

 

 

BAYVIEW ACQUISITION CORP

STATEMENTS OF OPERATIONS

(UNAUDITED)

 

		Three Months Ended March 31, 2024				For the Period from February 16, 2023 (Inception) Through March 31, 2023
Formation and operating costs		$	158,936			$	3,105
Loss from operations			(158,936	)			(3,105	)
Other Income:
Interest and dividend earned on securities held in trust account			754,312				-
Total other income			754,312				-
Net income (loss)		$	595,376			$	(3,105	)
Basic and diluted weighted average ordinary shares outstanding, redeemable ordinary shares			6,000,000				-
Basic and diluted net income per share, redeemable ordinary shares		$	0.11			$	-
Basic and diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares			1,799,258				1,500,000	(1)
Basic and diluted net loss per share, non-redeemable ordinary shares		$	(0.02	)		$	(0.00	)

 

(1)

Excludes an aggregate of up to 225,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter. On December 14, 2023, additional 287,500 shares were issued to the Sponsors for a consideration of $100. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively (see Note 5 and 7).

 

The accompanying notes are an integral part of these unaudited financial statement.

 

 

BAYVIEW ACQUISITION CORP

STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT

(UNAUDITED)

 

FOR THE THREE MONTHS ENDED MARCH 31, 2024

 

		Shares				Amount				Capital				Deficit)				Deficit
		Ordinary Shares								Additional Paid-in				Retained Earnings (Accumulated				Total Shareholders’
		Shares				Amount				Capital				Deficit)				Deficit
Balance as of January 1, 2024			1,957,500			$	196			$	-			$	(1,729,956	)		$	(1,729,760	)
Forfeiture of ordinary shares by Sponsors			(225,000	)			(23	)			23				-				-
Subsequent measurement of ordinary shares subject to possible redemption (interest earned on trust account)			-				-				(23	)			(754,289	)			(754,312	)
Net income			-				-				-				595,376				595,376
Balance as of March 31, 2024			1,732,500			$	173			$	-			$	(1,888,869	)		$	(1,888,696	)

 

FOR THE PERIOD FROM FEBRUARY 16, 2023 (INCEPTION) THROUGH MARCH 31, 2023

 

		Ordinary Shares								Additional Paid-in				Retained Earnings (Accumulated				Total Shareholders’
		Shares (1)				Amount				Capital				Deficit)				Equity
Balance as of February 16, 2023			-			$	-			$	-			$	-			$	-
Balance			-			$	-			$	-			$	-			$	-
Issuance of ordinary shares to Sponsors			1,725,000				173				24,927				-				25,100
Net loss			-				-				-				(3,105	)			(3,105	)
Net income (loss)			-				-				-				(3,105	)			(3,105	)
Balance as of March 31, 2023			1,725,000			$	173			$	24,927			$	(3,105	)		$	21,995
Balance			1,725,000			$	173			$	24,927			$	(3,105	)		$	21,995

 

(1)

Includes up to 225,000 shares of ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriter. On December 14, 2023, additional 287,500 shares were issued to the Sponsors for a consideration of $100. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively (see Note 5 and 7).

 

The accompanying notes are an integral part of these unaudited financial statement.

 

 

BAYVIEW ACQUISITION CORP

STATEMENT OF CASH FLOWS

(UNAUDITED)

 

		For the Three Months Ended March 31, 2024				For the Period from February 16, 2023 (inception) through March 31, 2023
Cash flows from operating activities:
Net income (loss)		$	595,376				(3,105	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Income earned on investments held in Trust Account			(754,312	)			-
Accrued offering costs and expenses			35,563
Prepaid expenses			(87,386	)			-
Due to related party			(10,000	)			-
Other receivables			(29,677	)			-
Formation and operating costs			-				3,105
Net cash used in operating activities			(250,436	)			-
Net change in cash			(250,436	)			-
Cash at beginning of period			582,308				-
Cash at end of period		$	331,872				-
Supplemental disclosure of noncash investing and financing activities
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)			754,312				-
Deferred offering costs paid by Sponsors in exchange for issuance of ordinary shares			-				25,100
Deferred offering costs paid by related party			-				113,305
Deferred offering costs included in accrued expenses			-				15,995
Prepaid expenses included in due to related party		$	-			$	1,429

 

The accompanying notes are an integral part of these unaudited financial statement.

 

 

BAYVIEW ACQUISITION CORP

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2024

(UNAUDITED)

 

NOTE 1 —ORGANIZATION AND BUSINESS OPERATIONS

 

Organizational and General

 

Bayview Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on February 16, 2023. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities (the “Business Combination”).

 

The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

The Company’s sponsors are Peace Investment Holdings Limited, a British Virgin Islands company, and Bayview Holding LP, a Delaware limited partnership (the “Sponsors”). As of March 31, 2024, the Company had not commenced any operations. All activities for the period from February 16, 2023 (inception) through March 31, 2024 related to the Company’s formation and the initial public offering (“IPO”), and subsequent to the IPO, identifying a target company for an initial Business Combination. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest or dividend income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

 

The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on December 14, 2023. Additionally, on December 14, 2023, the Company filed a registration statement adding securities to the Registration Statement. On December 19, 2023, the Company consummated the IPO of 6,000,000 units, (“Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $60,000,000, which is described in Note 3, and the sale of 232,500 Units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in private placements to the Sponsors that was closed simultaneously with the IPO, generating gross proceeds of $2,325,000.

 

The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to 900,000 additional Units to cover over-allotment, if any, at the IPO price less the underwriting discounts and commissions. On January 28, 2024, the underwriter did not exercise their over-allotment option and hence a total of 225,000 ordinary shares were forfeited by the Sponsors.

 

The Company will have until 9 months from the closing of the Initial Public Offering (or up to 18 months, if we extend the time to complete a business combination as described in this prospectus) to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less certain amount of interest to pay liquidation and dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

Going Concern Consideration

 

As of March 31, 2024, the Company had cash of $331,872 and a working capital of $197,994. The Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.

 

5

 

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. These unaudited financial statements should be read in conjunction with the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed by the Company with the SEC on April 16, 2024.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

6

 

 

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalent balance of $331,872 and $582,308 as of March 31, 2024 and December 31, 2023, respectively.

 

Investments Held in Trust Account

 

The Company’s portfolio of investments held in the trust account is comprised of investments in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and Money Market Fund. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of March 31, 2024 and December 31, 2023, the Trust Account had balances of $60,861,367 and $60,107,055, respectively. The interests earned from the trust account totaled $754,312 for the three months ended March 31, 2024, which were held in the trust accounts as earned and therefore presented as an adjustment to the operating activities in the Statement of Cash Flows.

 

Offering Costs

 

Offering costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on December 19, 2023.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.

 

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

7

 

 

The net income (loss) per share presented in the statements of operations is based on the following:

 SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS 

		Three months ended				For the period from February 16, 2023 (inception)
		March 31, 2024				through March 31, 2023
Net income (loss)		$	595,376			$	(3,105	)
Income earned on investment held in Trust Account			(754,312	)			-
Net loss including accretion of equity into redemption value		$	(158,936	)		$	(3,105	)

 

SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED

		Redeemable				Non- Redeemable								Non- Redeemable
		Three months ended March 31, 2024								For the period from February 16, 2023 (inception) through March 31, 2023
		Redeemable				Non- Redeemable				Redeemable				Non- Redeemable
		Shares				Shares				Shares				Shares
Basic and diluted net income (loss) per share:
Weighted-average shares outstanding			6,000,000				1,799,258				-				1,500,000
Numerators:
Allocation of net loss including accretion of temporary equity		$	(122,270	)		$	(36,666	)			-			$	(3,105	)
Income earned on investment held in Trust Account			754,312				—				-				—
Allocation of net income (loss)			632,042				(36,666	)			-				(3,105	)
Denominators:
Weighted-average shares outstanding			6,000,000				1,799,258				-				1,500,000
Basic and diluted net income (loss) per share		$	0.11			$	(0.02	)			-			$	(0.00	)

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

8

 

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

 

At March 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET

Public offering proceeds		$	60,000,000
Less:
Proceeds allocated to Public Rights			(2,460,000	)
Allocation of offering costs related to redeemable shares			(4,163,327	)
Plus:
Accretion of carrying value to redemption value			6,623,327
Ordinary shares subject to possible redemption		$	60,000,000
Plus:
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)			107,055
Ordinary shares subject to possible redemption as of December 31, 2023		$	60,107,055
Plus:
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)			754,312
Ordinary shares subject to possible redemption as of March 31, 2024			60,861,367

 

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

 

NOTE 3 — INITIAL PUBLIC OFFERING

 

On December 19, 2023, the Company sold 6,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights.

 

NOTE 4 — PRIVATE PLACEMENTS

 

Simultaneously with the closing of the IPO, the Company consummated the private sale of 232,500 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $2,325,000. Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. The proceeds from the sale of the Private Placement Units were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to certain exceptions.

 

9

 

 

NOTE 5 — RELATED PARTIES

 

Founder Shares

 

On February 23, 2023, our sponsor, Bayview Holding LP, acquired 1,437,500 founder shares for an aggregate price of $25,000. 963,125 founder shares were transferred to our sponsor Peace Investment Holdings Limited on March 14, 2023.

 

On December 14, 2023, the Company issued 287,500 founder shares for a consideration of $100, resulting in Bayview Holding LP holding a total of 569,250 founder shares and Peace Investment Holdings Limited holding a total of 1,155,750 founder shares. The payment of $100 was received on December 27, 2023. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively.

 

On January 28, 2024, a total of 225,000 ordinary shares were forfeited by the Sponsors subsequent to the IPO as the underwriter’s over-allotment option was not exercised.

 

Promissory Note — Related Party

 

On February 23, 2023, the Sponsors issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. On the date of closing of the IPO, no amounts were outstanding under the Promissory Note and the Promissory Note then expired upon the consummation of the IPO.

 

Due to Related Party

 

The Sponsors paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts were due on demand and non-interest bearing, which was fully repaid upon closing of the IPO on December 19, 2023. As of March 31, 2024 and December 31, 2023, amount due to related party was 0 and $10,000 for the administration service fee, respectively.

 

10

 

 

NOTE 6 — COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Units, securities underlying the unit purchase option (“UPO”), and Units that may be issued upon conversion of working capital loans (and all underlying securities) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriter a 45-day option from the date of IPO to purchase up to 900,000 additional Units to cover over-allotment, at the IPO price less the underwriting discounts and commissions. On January 28, 2024, the underwriter did not exercise their over-allotment option and hence a total of 225,000 ordinary shares were forfeited by the Sponsors.

 

The underwriter was entitled to a cash underwriting discounts of $0.20 per Unit, or $1,200,000 in the aggregate (or $1,380,000 in the aggregate if the underwriter’s over-allotment option is exercised in full), payable upon the closing of the IPO. The cash underwriting discount of $1,200,000 was paid on December 19, 2023.

 

The underwriter will be entitled to a deferred commission of $0.35 per Unit, or $2,100,000 in the aggregate. The deferred commission will be paid to the underwriters from the amounts held in the escrow trust account solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement. The deferred underwriting commission was reported as non-current liability on the balance sheet dated March 31, 2024.

 

Unit Purchase Option

 

We have agreed to sell to Chardan and/or its designees, for $100, an option to purchase a total of 540,000 units exercisable, in whole or in part, at $11.50 per unit (or 115% of the volume weighted average price of the ordinary shares during the 20 trading day period starting on the trading day immediately prior to consummation of an initial Business Combination), commencing on the consummation of our initial Business Combination, and expires five years from the effective date of this offering. The option and the 540,000 units, as well as the 540,000 Ordinary Shares and the rights to purchase 54,000 Ordinary Shares upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement of which this prospectus forms a part or the commencement of sales in this offering pursuant to Rule 5110(e)(1) of FINRA’s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the securities, except as permitted under FINRA Rule 5110(e)(2).

 

Business Combination Transaction Costs

 

The Company has engaged several service providers specifically for the potential business combination. Per the agreed terms with the potential target company, the potential target company will be responsible for the expenses incurred in connection with the business combination. During the three months ended March 31, 2024, $170,000 of business combination related cost has been incurred. As of March 31, 2024, the receivable from the potential target company and accrued to service providers was $170,000.

 

NOTE 7 — SHAREHOLDERS’ EQUITY

 

Preferred Shares — The Company is authorized to issue 2,000,000 preferred shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2024, there were no preferred shares issued or outstanding.

 

Ordinary Shares — The Company is authorized to issue 200,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share.

 

On February 23, 2023, our sponsor, Bayview Holding LP, acquired 1,437,500 founder shares for an aggregate price of $25,000. 963,125 founder shares were transferred to our sponsor Peace Investment Holdings Limited on March 14, 2023.

 

11

 

 

On December 14, 2023, the Company issued 287,500 founder shares for a consideration of $100, resulting in Bayview Holding LP holding a total of 569,250 founder shares and Peace Investment Holdings Limited holding a total of 1,155,750 founder shares. The payment of $100 was received on December 27, 2023. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. On January 28, 2024, a total of 225,000 ordinary shares were forfeited by the Sponsors as the underwriters did not exercise their over-allotment option.

 

Considered the nominal issuance, there was 1,725,00 ordinary shares issued and outstanding and no 6,000,000 public ordinary shares subject to redemption as of March 31, 2023. A total of 225,000 ordinary shares held by the Sponsors were subject to forfeiture as of March 31, 2023.

 

As of March 31, 2024 and December 31, 2023, there were 1,732,500 and 1,957,500 ordinary shares issued and outstanding, respectively, excluding the 6,000,000 ordinary shares subject to possible redemption, which are presented as temporary equity.

 

Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.

 

NOTE 8 — Fair Value Measurements

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

 

Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

 

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS

Quoted

Significant

Significant

Prices in

Other

Other

As of

Active

Observable

Unobservable

March 31,

Markets

Inputs

Inputs

2024

(Level 1)

(Level 2)

(Level 3)

Assets:

Investment held in trust account

$

60,861,367

$

60,861,367

$

—

$

—

 

Quoted

Significant

Significant

As of

Prices in

Other

Other

December

Active

Observable

Unobservable

31,

Markets

Inputs

Inputs

2023

(Level 1)

(Level 2)

(Level 3)

Assets:

Investment held in trust account

$

60,107,055

$

60,107,055

$

—

$

—

 

NOTE 9 — SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on the review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References to the “Company,” “Bayview,” “our,” “us” or “we” refer to Bayview Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim financial statements and the notes thereto contained elsewhere in this report. As well as the Company’s 2023 Annual Report on Form 10-K as filed with the SEC on April 16, 2023. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (“SEC”) filings.

 

Overview

 

We are a blank check company incorporated on February 16, 2023, as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, which we refer to throughout the Registration Statement as our initial business combination. We have generated no revenues to date, and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us.

 

Results of Operations and Known Trends or Future Events

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities since February 16, 2023 (inception) to March 31, 2024, have been organizational activities and those necessary to prepare for the Initial Public Offering (the “IPO”) described below and identifying a target company for initial Business Combination.. Following our IPO, we would not generate any operating revenues until the completion of our initial business combination. We would generate non-operating income in the form of interest income after the IPO. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

 

For the three months ended March 31, 2024, we had a net income of $595,376, which consists of income earned on investment held in Trust Account of $754,312 offset by loss of $158,936 derived from formation and operating costs.

 

For the period from February 16, 2023 (inception) through March 31, 2023, we had a net loss of $3,105, which consists of loss of $3,105 derived from formation and operating costs.

 

Liquidity and Capital Resources

 

On December 19, 2023, we consummated our IPO of 6,000,000 Units, at $10.00 per Unit, generating gross proceeds of $60,000,000. Simultaneously with the closing of the IPO, we consummated the sale of 232,500 Private Placement Units at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $2,325,000. Following the closing of the IPO, an amount of $60,000,000 from the net proceeds of the sale of the Units in the IPO and the Private Placement was held in a trust account. The funds held in the trust account may be invested in U.S. government securities with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us.

 

 

We granted the underwriter a 45-day option to purchase up to an additional 900,000 Units at the IPO price to cover over-allotment, if any. On January 28, 2023, a total of 225,000 ordinary shares were forfeited by the Sponsors since the underwriter did not exercise their over-allotment option.

 

As of March 31, 2024, our cash and cash equivalent balance was $331,872. We will use these funds primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.

 

We expect our primary liquidity requirements during that period to include approximately $200,000 in legal, accounting, due diligence and other fees in connection with the business combination; $100,000 in legal and accounting related to regulatory reporting obligations, $120,000 for office space, administrative and support services, $55,000 in NASDAQ continued listing fees and $100,000 for miscellaneous expenses, including director and officer’s liability insurance, general corporate purposes, liquidation obligations and reserves.

 

As indicated in the accompanying financial statements, as of March 31, 2024, we had a working capital of $197,994. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans.

 

Quantitative and Qualitative Disclosures about Market Risk

 

The net proceeds of the IPO and the sale of the Private Placement Units held in the trust account will be invested in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

 

Related Party Transactions

 

Please refer to Financial Statements Note 5 – Related Parties.

 

Off-Balance Sheet Arrangements; Commitments and Contractual Obligations; Quarterly Results

 

As of March 31, 2024, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations. No unaudited quarterly operating data is included in the Registration Statement, as we have conducted no operations to date.

 

JOBS Act

 

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company”, we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of the IPO or until we are no longer an “emerging growth company,” whichever is earlier.

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of March 31, 2024, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of March 31, 2024, our disclosure controls and procedures were effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Management’s Report on Internal Controls Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) and for our assessment of the effectiveness of internal control over financial reporting. Our internal control over financial reporting is a process designed under the supervision of our Chief Executive Officer and our Chief Financial Officer, and effected by our Board, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with U.S. generally accepted accounting principles and includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management, including our Chief Executive Officer and Chief Financial Officer, has conducted an assessment regarding the effectiveness of our internal control over financial reporting as of March 31, 2024, based on the framework established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment under the criteria described above, management has concluded that our internal control over financial reporting was not effective as of March 31, 2024, solely due to the material weakness in our internal control over financial reporting related to the Company’s lack of qualified SEC reporting professional. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. GAAP. Accordingly, management believes that the financial statements included in this Form 10-Q present fairly, in all material respects, our financial position, result of operations and cash flows for the periods presented. Management intends to continue implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we intend to expand and improve our review process for complex securities and related accounting standards. We have improved this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in (i) our final prospectus for our Initial Public Offering filed with the SEC on December 19, 2023, and (ii) our annual report on Form 10-K filed with the SEC on April 16, 2024. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in (i) our final prospectus for our Initial Public Offering filed with the SEC on December 19, 2023 or (ii) our annual report on Form 10-K filed with the SEC on April 16, 2024, except we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Unregistered Sales of Equity Securities

 

On February 23, 2023, our sponsor, Bayview Holding LP acquired 1,437,500 founder shares for an aggregate purchase price of $25,000, of which Bayview Holding LP owns 474,375 ordinary shares and Peace Investment Holdings Limited owns 963,125 ordinary shares. On December 14, 2023, the Company issued an additional 287,500 founder shares for consideration of $100, resulting in Bayview Holding LP holding a total of 569,250 founder shares and Peace Investment Holdings Limited holding a total of 1,155,750 founder shares as of the date of the Registration Statement. On January 28, 2024, a total of 225,000 founder shares were forfeited by the Sponsors as the underwriters did not exercise their over-allotment option.

 

Simultaneously with the closing of the IPO, pursuant to a Private Placement Unit Purchase Agreement, the Company completed the private sale of 232,500 Private Placement Units to the Sponsors at a purchase price of $10.00 per Private Placement Unit generating gross proceeds to the Company of $2,325,000. The Private Placement Units are identical to the Units sold in the IPO. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Use of Proceeds

 

On December 19, 2023, the Company consummated the initial public offering of 6,000,000 Units (the “Units” and, with respect to the Ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $60,000,000.

 

Simultaneously with the closing of the initial public offering, we consummated the sale of 232,500 Private Placement Units at a price of $10.00 per Unit, generating gross proceeds of $2,325,000.

 

On February 23, 2023, we issued an unsecured promissory note to our Sponsors (the “Promissory Note”), pursuant to which we received proceeds of $300,000 to cover expenses related to the initial public offering. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. As of December 19, 2023, there were no amounts outstanding under the Promissory Note and the Promissory Note then expired.

 

Transaction costs related to the issuances described above amounted to $4,341,321, consisting of $1,200,000 of cash underwriting fees, $2,100,000 of deferred underwriting fees and $1,041,321 of other offering costs. After deducting the underwriting discounts and commissions and offering expenses, the total net proceeds from the initial public offering and the sale of the Private Placement Units $60,000,000 (or $10.00 per share sold in the initial public offering) was placed in the Trust Account.

 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit No.		Description
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.

**These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

BAYVIEW ACQUISITION CORP
By:	/s/ Xin Wang
Name:	Xin Wang
Title:	Principal Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Quarterly Report has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature		Position		Date
/s/Xin Wang		Principal Executive Officer and Director		May 15, 2024
Xin Wang		(Principal Executive Officer)
/s/ David Bamper		Principal Financial Officer		May 15, 2024
David Bamper		(Principal Financial Officer and Principal Accounting Officer)
/s/ Yuk Man Lau		Chairman		May 15, 2024
Yuk Man Lau

 

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Xin Wang, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Bayview Acquisition Corp;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2024	By:	/s/ Xin Wang
		Xin Wang
		Chief Executive Officer
		(Principal Executive Officer)

 

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, David Bamper, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Bayview Acquisition Corp;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2024	By:	/s/ David Bamper
		David Bamper
		Chief Financial Officer
		(Principal Financial Officer)

 

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER 

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Bayview Acquisition Corp (the “Registrant”) on Form 10-Q for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: May 15, 2024	By:	/s/ Xin Wang
		Xin Wang
		Chief Executive Officer
		(Principal Executive Officer)

 

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Bayview Acquisition Corp (the “Registrant”) on Form 10-Q for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: May 15, 2024	By:	/s/ David Bamper
		David Bamper
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

 

v3.24.1.1.u2

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 15, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-41890
Entity Registrant Name	BAYVIEW ACQUISITION CORP
Entity Central Index Key	0001969475
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	420 Lexington Ave, Suite 2446
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10170
City Area Code	(347)
Local Phone Number	627-0058
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		7,732,500
Units, each Consisting of One Ordinary Share and One Right [Member]
Title of 12(b) Security	Units, each consisting of one ordinary share and one right
Trading Symbol	BAYAU
Security Exchange Name	NASDAQ
Common Stock, Par Value $0.0001 Per Share [Member]
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	BAYA
Security Exchange Name	NASDAQ
Rights, each Right Entitling the Holder thereof to One-tenth of One Ordinary Share [Member]
Title of 12(b) Security	Rights, each right entitling the holder thereof to one-tenth of one ordinary share
Trading Symbol	BAYAR
Security Exchange Name	NASDAQ

v3.24.1.1.u2

Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 331,872	$ 582,308
Other receivables (Note 6)	199,677
Prepaid expenses	132,500	72,014
Total current assets	664,049	654,322
Prepaid expenses – non-current	13,310	29,677
Investment held in trust account	60,861,367	60,107,055
Total Assets	61,538,726	60,791,054
Current liabilities:
Accrued offering costs and expenses	466,055	303,759
Total Current Liabilities	466,055	313,759
Deferred underwriting commission payable	2,100,000	2,100,000
Total Liabilities	2,566,055	2,413,759
Commitments and contingencies
Ordinary shares subject to possible redemption (6,000,000 shares at redemption value of $10.14 and $10.02 as of March 31, 2024 and December 31, 2023, respectively)	60,861,367	60,107,055
Shareholders’ Deficit:
Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,732,500 and 1,957,500 shares issued and outstanding (excluding 6,000,000 shares subject to possible redemption) at March 31, 2024 and December 31, 2023, respectively	173	196
Additional paid-in capital
Accumulated deficit	(1,888,869)	(1,729,956)
Total Shareholders’ Deficit	(1,888,696)	(1,729,760)
Total Liabilities and Shareholders’ Deficit	61,538,726	60,791,054
Related Party [Member]
Current liabilities:
Due to related party		$ 10,000

v3.24.1.1.u2

Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Ordinary shares subject to possible redemption, shares	6,000,000	6,000,000
Ordinary shares, redemption price per share	$ 10.14	$ 10.02
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	200,000,000	200,000,000
Ordinary shares, shares issued	1,732,500	1,957,500
Ordinary shares, shares outstanding	1,732,500	1,957,500

v3.24.1.1.u2

Statements of Operations (Unaudited) - USD ($)	2 Months Ended		3 Months Ended
	Mar. 31, 2023		Mar. 31, 2024
Formation and operating costs	$ 3,105		$ 158,936
Loss from operations	(3,105)		(158,936)
Other Income:
Interest and dividend earned on securities held in trust account			754,312
Total other income			754,312
Net income (loss)	$ (3,105)		$ 595,376
Redeemable Common Stock [Member]
Other Income:
Weighted average ordinary shares outstanding - basic			6,000,000
Weighted average ordinary shares outstanding - diluted			6,000,000
Net income (loss) per share - basic			$ 0.11
Net income (loss) per share - diluted			$ 0.11
Non-redeemable Common Stock [Member]
Other Income:
Weighted average ordinary shares outstanding - basic	1,500,000	[1]	1,799,258
Weighted average ordinary shares outstanding - diluted	1,500,000	[1]	1,799,258
Net income (loss) per share - basic	$ (0.00)		$ (0.02)
Net income (loss) per share - diluted	$ (0.00)		$ (0.02)
[1] Excludes an aggregate of up to 225,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter. On December 14, 2023, additional 287,500 shares were issued to the Sponsors for a consideration of $100. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively (see Note 5 and 7).

v3.24.1.1.u2

Statements of Operations (Unaudited) (Parenthetical) - USD ($)		2 Months Ended
	Dec. 14, 2023	Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Shares forfeiture		225,000
Stock issued value new issues		$ 25,100
Sponsor [Member]
Defined Benefit Plan Disclosure [Line Items]
Stock issued shares new issues	287,500
Stock issued value new issues	$ 100

v3.24.1.1.u2

Statement of Changes in Shareholders' Deficit (Unaudited) - USD ($)		Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Feb. 15, 2023
Balance, shares at Feb. 15, 2023	[1]
Net income (loss)				(3,105)	(3,105)
Issuance of ordinary shares to Sponsors		$ 173	24,927		25,100
Issuance of ordinary shares to Sponsors, shares	[1]	1,725,000
Balance at Mar. 31, 2023		$ 173	24,927	(3,105)	21,995
Balance, shares at Mar. 31, 2023	[1]	1,725,000
Balance at Dec. 31, 2023		$ 196		(1,729,956)	(1,729,760)
Balance, shares at Dec. 31, 2023		1,957,500
Forfeiture of ordinary shares by Sponsors		$ (23)	23
Forfeiture of ordinary shares by Sponsors, shares		(225,000)
Subsequent measurement of ordinary shares subject to possible redemption (interest earned on trust account)			(23)	(754,289)	(754,312)
Net income (loss)				595,376	595,376
Balance at Mar. 31, 2024		$ 173		$ (1,888,869)	$ (1,888,696)
Balance, shares at Mar. 31, 2024		1,732,500
[1] Includes up to 225,000 shares of ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriter. On December 14, 2023, additional 287,500 shares were issued to the Sponsors for a consideration of $100. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively (see Note 5 and 7).

v3.24.1.1.u2

Statement of Changes in Shareholders' Deficit (Unaudited) (Parenthetical) - USD ($)		2 Months Ended
	Dec. 14, 2023	Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Shares forfeiture		225,000
Stock issued value new issues		$ 25,100
Sponsor [Member]
Defined Benefit Plan Disclosure [Line Items]
Stock issued shares new issues	287,500
Stock issued value new issues	$ 100

v3.24.1.1.u2

Statement of Cash Flows (Unaudited) - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ (3,105)	$ 595,376
Adjustments to reconcile net loss to net cash provided by operating activities:
Income earned on investments held in Trust Account		(754,312)
Accrued offering costs and expenses		35,563
Prepaid expenses		(87,386)
Due to related party		(10,000)
Other receivables		(29,677)
Formation and operating costs	3,105
Net cash used in operating activities		(250,436)
Net change in cash		(250,436)
Cash at beginning of period		582,308
Cash at end of period		331,872
Supplemental disclosure of noncash investing and financing activities
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)		754,312
Deferred offering costs paid by Sponsors in exchange for issuance of ordinary shares	25,100
Deferred offering costs paid by related party	113,305
Deferred offering costs included in accrued expenses	15,995
Prepaid expenses included in due to related party	$ 1,429

v3.24.1.1.u2

ORGANIZATION AND BUSINESS OPERATIONS	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1 —ORGANIZATION AND BUSINESS OPERATIONS   Organizational and General   Bayview Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on February 16, 2023. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities (the “Business Combination”).   The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.   The Company’s sponsors are Peace Investment Holdings Limited, a British Virgin Islands company, and Bayview Holding LP, a Delaware limited partnership (the “Sponsors”). As of March 31, 2024, the Company had not commenced any operations. All activities for the period from February 16, 2023 (inception) through March 31, 2024 related to the Company’s formation and the initial public offering (“IPO”), and subsequent to the IPO, identifying a target company for an initial Business Combination. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest or dividend income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.   The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on December 14, 2023. Additionally, on December 14, 2023, the Company filed a registration statement adding securities to the Registration Statement. On December 19, 2023, the Company consummated the IPO of 6,000,000 units, (“Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $60,000,000, which is described in Note 3, and the sale of 232,500 Units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in private placements to the Sponsors that was closed simultaneously with the IPO, generating gross proceeds of $2,325,000.   The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to 900,000 additional Units to cover over-allotment, if any, at the IPO price less the underwriting discounts and commissions. On January 28, 2024, the underwriter did not exercise their over-allotment option and hence a total of 225,000 ordinary shares were forfeited by the Sponsors.   The Company will have until 9 months from the closing of the Initial Public Offering (or up to 18 months, if we extend the time to complete a business combination as described in this prospectus) to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less certain amount of interest to pay liquidation and dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.   Going Concern Consideration   As of March 31, 2024, the Company had cash of $331,872 and a working capital of $197,994. The Company has incurred and expects to continue to incur significant professional costs to remain as a public traded company and to incur transaction costs in pursuit of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period and such period is not extended, there will be a liquidation and subsequent dissolution. As a result, management has determined that such additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of Presentation   The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. These unaudited financial statements should be read in conjunction with the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed by the Company with the SEC on April 16, 2024.   Emerging Growth Company   The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.   Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.   Use of Estimates   The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.   Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.     Cash and cash equivalents   The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalent balance of $331,872 and $582,308 as of March 31, 2024 and December 31, 2023, respectively.   Investments Held in Trust Account   The Company’s portfolio of investments held in the trust account is comprised of investments in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and Money Market Fund. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of March 31, 2024 and December 31, 2023, the Trust Account had balances of $60,861,367 and $60,107,055, respectively. The interests earned from the trust account totaled $754,312 for the three months ended March 31, 2024, which were held in the trust accounts as earned and therefore presented as an adjustment to the operating activities in the Statement of Cash Flows.   Offering Costs   Offering costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on December 19, 2023.   Income Taxes   The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.   ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.   There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.   Net Income (Loss) per Ordinary Share   The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.     The net income (loss) per share presented in the statements of operations is based on the following:  SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS      Three months ended     For the period from February 16, 2023 (inception)       March 31, 2024     through March 31, 2023   Net income (loss)   $ 595,376     $ (3,105 ) Income earned on investment held in Trust Account     (754,312 )     -   Net loss including accretion of equity into redemption value   $ (158,936 )   $ (3,105 )   SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED     Redeemable     Non- Redeemable             Non- Redeemable       Three months ended March 31, 2024     For the period from February 16, 2023 (inception) through March 31, 2023       Redeemable     Non- Redeemable     Redeemable     Non- Redeemable       Shares     Shares     Shares     Shares   Basic and diluted net income (loss) per share:                                        Weighted-average shares outstanding     6,000,000       1,799,258       -       1,500,000                                     Numerators:                                 Allocation of net loss including accretion of temporary equity   $ (122,270 )   $ (36,666 )     -     $ (3,105 ) Income earned on investment held in Trust Account     754,312       —       -       —   Allocation of net income (loss)     632,042       (36,666 )     -       (3,105 )                                   Denominators:                                 Weighted-average shares outstanding     6,000,000       1,799,258       -       1,500,000   Basic and diluted net income (loss) per share   $ 0.11     $ (0.02 )     -     $ (0.00 )   Concentration of Credit Risk   Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.     Fair Value of Financial Instruments   The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.   Ordinary Shares Subject to Possible Redemption   The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.   At March 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:   SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET Public offering proceeds   $ 60,000,000   Less:         Proceeds allocated to Public Rights     (2,460,000 ) Allocation of offering costs related to redeemable shares     (4,163,327 ) Plus:         Accretion of carrying value to redemption value     6,623,327   Ordinary shares subject to possible redemption   $ 60,000,000   Plus:         Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     107,055   Ordinary shares subject to possible redemption as of December 31, 2023   $ 60,107,055   Plus:         Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     754,312   Ordinary shares subject to possible redemption as of March 31, 2024     60,861,367     Recent Accounting Standards   Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

v3.24.1.1.u2

INITIAL PUBLIC OFFERING	3 Months Ended
	Mar. 31, 2024
Initial Public Offering
INITIAL PUBLIC OFFERING	NOTE 3 — INITIAL PUBLIC OFFERING   On December 19, 2023, the Company sold 6,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights.

v3.24.1.1.u2

PRIVATE PLACEMENTS	3 Months Ended
	Mar. 31, 2024
Private Placements
PRIVATE PLACEMENTS	NOTE 4 — PRIVATE PLACEMENTS   Simultaneously with the closing of the IPO, the Company consummated the private sale of 232,500 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $2,325,000. Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. The proceeds from the sale of the Private Placement Units were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units (including the underlying securities) will not be transferable, assignable, or salable until the completion of a Business Combination, subject to certain exceptions.

v3.24.1.1.u2

RELATED PARTIES	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTIES	NOTE 5 — RELATED PARTIES   Founder Shares   On February 23, 2023, our sponsor, Bayview Holding LP, acquired 1,437,500 founder shares for an aggregate price of $25,000. 963,125 founder shares were transferred to our sponsor Peace Investment Holdings Limited on March 14, 2023.   On December 14, 2023, the Company issued 287,500 founder shares for a consideration of $100, resulting in Bayview Holding LP holding a total of 569,250 founder shares and Peace Investment Holdings Limited holding a total of 1,155,750 founder shares. The payment of $100 was received on December 27, 2023. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively.   On January 28, 2024, a total of 225,000 ordinary shares were forfeited by the Sponsors subsequent to the IPO as the underwriter’s over-allotment option was not exercised.   Promissory Note — Related Party   On February 23, 2023, the Sponsors issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. On the date of closing of the IPO, no amounts were outstanding under the Promissory Note and the Promissory Note then expired upon the consummation of the IPO.   Due to Related Party   The Sponsors paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts were due on demand and non-interest bearing, which was fully repaid upon closing of the IPO on December 19, 2023. As of March 31, 2024 and December 31, 2023, amount due to related party was 0 and $10,000 for the administration service fee, respectively.

v3.24.1.1.u2

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 — COMMITMENTS AND CONTINGENCIES   Registration Rights   The holders of the Founder Shares, Private Placement Units, securities underlying the unit purchase option (“UPO”), and Units that may be issued upon conversion of working capital loans (and all underlying securities) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.   Underwriting Agreement   The Company granted the underwriter a 45-day option from the date of IPO to purchase up to 900,000 additional Units to cover over-allotment, at the IPO price less the underwriting discounts and commissions. On January 28, 2024, the underwriter did not exercise their over-allotment option and hence a total of 225,000 ordinary shares were forfeited by the Sponsors.   The underwriter was entitled to a cash underwriting discounts of $0.20 per Unit, or $1,200,000 in the aggregate (or $1,380,000 in the aggregate if the underwriter’s over-allotment option is exercised in full), payable upon the closing of the IPO. The cash underwriting discount of $1,200,000 was paid on December 19, 2023.   The underwriter will be entitled to a deferred commission of $0.35 per Unit, or $2,100,000 in the aggregate. The deferred commission will be paid to the underwriters from the amounts held in the escrow trust account solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement. The deferred underwriting commission was reported as non-current liability on the balance sheet dated March 31, 2024.   Unit Purchase Option   We have agreed to sell to Chardan and/or its designees, for $100, an option to purchase a total of 540,000 units exercisable, in whole or in part, at $11.50 per unit (or 115% of the volume weighted average price of the ordinary shares during the 20 trading day period starting on the trading day immediately prior to consummation of an initial Business Combination), commencing on the consummation of our initial Business Combination, and expires five years from the effective date of this offering. The option and the 540,000 units, as well as the 540,000 Ordinary Shares and the rights to purchase 54,000 Ordinary Shares upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement of which this prospectus forms a part or the commencement of sales in this offering pursuant to Rule 5110(e)(1) of FINRA’s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the securities, except as permitted under FINRA Rule 5110(e)(2).   Business Combination Transaction Costs   The Company has engaged several service providers specifically for the potential business combination. Per the agreed terms with the potential target company, the potential target company will be responsible for the expenses incurred in connection with the business combination. During the three months ended March 31, 2024, $170,000 of business combination related cost has been incurred. As of March 31, 2024, the receivable from the potential target company and accrued to service providers was $170,000.

v3.24.1.1.u2

SHAREHOLDERS’ EQUITY	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
SHAREHOLDERS’ EQUITY	NOTE 7 — SHAREHOLDERS’ EQUITY   Preferred Shares — The Company is authorized to issue 2,000,000 preferred shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2024, there were no preferred shares issued or outstanding.   Ordinary Shares — The Company is authorized to issue 200,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share.   On February 23, 2023, our sponsor, Bayview Holding LP, acquired 1,437,500 founder shares for an aggregate price of $25,000. 963,125 founder shares were transferred to our sponsor Peace Investment Holdings Limited on March 14, 2023.     On December 14, 2023, the Company issued 287,500 founder shares for a consideration of $100, resulting in Bayview Holding LP holding a total of 569,250 founder shares and Peace Investment Holdings Limited holding a total of 1,155,750 founder shares. The payment of $100 was received on December 27, 2023. The issuance was considered as a nominal issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. On January 28, 2024, a total of 225,000 ordinary shares were forfeited by the Sponsors as the underwriters did not exercise their over-allotment option.   Considered the nominal issuance, there was 1,725,00 ordinary shares issued and outstanding and no 6,000,000 public ordinary shares subject to redemption as of March 31, 2023. A total of 225,000 ordinary shares held by the Sponsors were subject to forfeiture as of March 31, 2023.   As of March 31, 2024 and December 31, 2023, there were 1,732,500 and 1,957,500 ordinary shares issued and outstanding, respectively, excluding the 6,000,000 ordinary shares subject to possible redemption, which are presented as temporary equity.   Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the business combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.

v3.24.1.1.u2

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 8 — Fair Value Measurements   The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:   Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.   Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.   Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.   The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.   SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS           Quoted     Significant     Significant             Prices in     Other     Other       As of     Active     Observable     Unobservable       March 31,     Markets     Inputs     Inputs       2024     (Level 1)     (Level 2)     (Level 3)   Assets:                                 Investment held in trust account   $ 60,861,367     $ 60,861,367     $     —     $     —               Quoted     Significant     Significant       As of     Prices in     Other     Other       December     Active     Observable     Unobservable       31,     Markets     Inputs     Inputs       2023     (Level 1)     (Level 2)     (Level 3)   Assets:                                 Investment held in trust account   $ 60,107,055     $ 60,107,055     $    —     $    —

v3.24.1.1.u2

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 — SUBSEQUENT EVENTS   The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on the review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation   The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. These unaudited financial statements should be read in conjunction with the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed by the Company with the SEC on April 16, 2024.
Emerging Growth Company	Emerging Growth Company   The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.   Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates   The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.   Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents   The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalent balance of $331,872 and $582,308 as of March 31, 2024 and December 31, 2023, respectively.
Investments Held in Trust Account	Investments Held in Trust Account   The Company’s portfolio of investments held in the trust account is comprised of investments in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and Money Market Fund. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of March 31, 2024 and December 31, 2023, the Trust Account had balances of $60,861,367 and $60,107,055, respectively. The interests earned from the trust account totaled $754,312 for the three months ended March 31, 2024, which were held in the trust accounts as earned and therefore presented as an adjustment to the operating activities in the Statement of Cash Flows.
Offering Costs	Offering Costs   Offering costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on December 19, 2023.
Income Taxes	Income Taxes   The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.   ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.   There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share   The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.     The net income (loss) per share presented in the statements of operations is based on the following:  SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS      Three months ended     For the period from February 16, 2023 (inception)       March 31, 2024     through March 31, 2023   Net income (loss)   $ 595,376     $ (3,105 ) Income earned on investment held in Trust Account     (754,312 )     -   Net loss including accretion of equity into redemption value   $ (158,936 )   $ (3,105 )   SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED     Redeemable     Non- Redeemable             Non- Redeemable       Three months ended March 31, 2024     For the period from February 16, 2023 (inception) through March 31, 2023       Redeemable     Non- Redeemable     Redeemable     Non- Redeemable       Shares     Shares     Shares     Shares   Basic and diluted net income (loss) per share:                                        Weighted-average shares outstanding     6,000,000       1,799,258       -       1,500,000                                     Numerators:                                 Allocation of net loss including accretion of temporary equity   $ (122,270 )   $ (36,666 )     -     $ (3,105 ) Income earned on investment held in Trust Account     754,312       —       -       —   Allocation of net income (loss)     632,042       (36,666 )     -       (3,105 )                                   Denominators:                                 Weighted-average shares outstanding     6,000,000       1,799,258       -       1,500,000   Basic and diluted net income (loss) per share   $ 0.11     $ (0.02 )     -     $ (0.00 )
Concentration of Credit Risk	Concentration of Credit Risk   Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments   The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption   The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.   At March 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:   SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET Public offering proceeds   $ 60,000,000   Less:         Proceeds allocated to Public Rights     (2,460,000 ) Allocation of offering costs related to redeemable shares     (4,163,327 ) Plus:         Accretion of carrying value to redemption value     6,623,327   Ordinary shares subject to possible redemption   $ 60,000,000   Plus:         Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     107,055   Ordinary shares subject to possible redemption as of December 31, 2023   $ 60,107,055   Plus:         Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     754,312   Ordinary shares subject to possible redemption as of March 31, 2024     60,861,367
Recent Accounting Standards	Recent Accounting Standards   Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS	The net income (loss) per share presented in the statements of operations is based on the following:  SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS      Three months ended     For the period from February 16, 2023 (inception)       March 31, 2024     through March 31, 2023   Net income (loss)   $ 595,376     $ (3,105 ) Income earned on investment held in Trust Account     (754,312 )     -   Net loss including accretion of equity into redemption value   $ (158,936 )   $ (3,105 )
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED	SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED     Redeemable     Non- Redeemable             Non- Redeemable       Three months ended March 31, 2024     For the period from February 16, 2023 (inception) through March 31, 2023       Redeemable     Non- Redeemable     Redeemable     Non- Redeemable       Shares     Shares     Shares     Shares   Basic and diluted net income (loss) per share:                                        Weighted-average shares outstanding     6,000,000       1,799,258       -       1,500,000                                     Numerators:                                 Allocation of net loss including accretion of temporary equity   $ (122,270 )   $ (36,666 )     -     $ (3,105 ) Income earned on investment held in Trust Account     754,312       —       -       —   Allocation of net income (loss)     632,042       (36,666 )     -       (3,105 )                                   Denominators:                                 Weighted-average shares outstanding     6,000,000       1,799,258       -       1,500,000   Basic and diluted net income (loss) per share   $ 0.11     $ (0.02 )     -     $ (0.00 )
SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET	At March 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:   SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET Public offering proceeds   $ 60,000,000   Less:         Proceeds allocated to Public Rights     (2,460,000 ) Allocation of offering costs related to redeemable shares     (4,163,327 ) Plus:         Accretion of carrying value to redemption value     6,623,327   Ordinary shares subject to possible redemption   $ 60,000,000   Plus:         Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     107,055   Ordinary shares subject to possible redemption as of December 31, 2023   $ 60,107,055   Plus:         Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)     754,312   Ordinary shares subject to possible redemption as of March 31, 2024     60,861,367

v3.24.1.1.u2

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS	The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.   SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS           Quoted     Significant     Significant             Prices in     Other     Other       As of     Active     Observable     Unobservable       March 31,     Markets     Inputs     Inputs       2024     (Level 1)     (Level 2)     (Level 3)   Assets:                                 Investment held in trust account   $ 60,861,367     $ 60,861,367     $     —     $     —               Quoted     Significant     Significant       As of     Prices in     Other     Other       December     Active     Observable     Unobservable       31,     Markets     Inputs     Inputs       2023     (Level 1)     (Level 2)     (Level 3)   Assets:                                 Investment held in trust account   $ 60,107,055     $ 60,107,055     $    —     $    —

v3.24.1.1.u2

ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - USD ($)			2 Months Ended	3 Months Ended
	Jan. 28, 2024	Dec. 19, 2023	Mar. 31, 2023	Mar. 31, 2024	Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]
Number of shares forfeited by sponsors			225,000
Percentage of outstanding voting securities				100.00%
Cash				$ 331,872	$ 582,308
Working capital				$ 197,994
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of share units issued		6,000,000
Share price		$ 10.00
Proceeds from initial public offering		$ 60,000,000
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of share units issued		232,500
Share price		$ 10.00
Proceeds from private placement		$ 2,325,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during the period, shares				900,000
Number of shares forfeited by sponsors	225,000

v3.24.1.1.u2

SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details) - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2024
Accounting Policies [Abstract]
Net income (loss)	$ (3,105)	$ 595,376
Income earned on investment held in Trust Account		(754,312)
Net loss including accretion of equity into redemption value	$ (3,105)	$ (158,936)

v3.24.1.1.u2

SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2024
Income earned on investment held in Trust Account		$ 754,312
Redeemable Shares [Member]
Weighted average shares outstanding - basic		6,000,000
Weighted average shares outstanding - diluted		6,000,000
Basic net income/(loss) per share		$ 0.11
Diluted net income/(loss) per share		$ 0.11
Non-redeemable Shares [Member]
Weighted average shares outstanding - basic	1,500,000	1,799,258
Weighted average shares outstanding - diluted	1,500,000	1,799,258
Basic net income/(loss) per share	$ (0.00)	$ (0.02)
Diluted net income/(loss) per share	$ (0.00)	$ (0.02)
Redeemable Shares [Member]
Weighted average shares outstanding - basic		6,000,000
Weighted average shares outstanding - diluted		6,000,000
Allocation of net loss including accretion of temporary equity		$ (122,270)
Income earned on investment held in Trust Account		754,312
Allocation of net income (loss)		$ 632,042
Non-redeemable Shares [Member]
Weighted average shares outstanding - basic	1,500,000	1,799,258
Weighted average shares outstanding - diluted	1,500,000	1,799,258
Allocation of net loss including accretion of temporary equity	$ (3,105)	$ (36,666)
Income earned on investment held in Trust Account
Allocation of net income (loss)	$ (3,105)	$ (36,666)

v3.24.1.1.u2

SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Public offering proceeds			$ 60,000,000
Proceeds allocated to public rights			(2,460,000)
Allocation of offering costs related to redeemable shares			(4,163,327)
Accretion of carrying value to redemption value			6,623,327
Ordinary shares subject to possible redemption	$ 60,107,055	$ 60,000,000
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)	754,312	107,055
Ordinary shares subject to possible redemption	$ 60,861,367	$ 60,107,055	$ 60,000,000

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Cash and cash equivalents		$ 331,872	$ 582,308
Cash held in Trust Account		60,861,367	60,107,055
Interest and dividend earned on marketable securities held in trust account		754,312
Unrecognized tax benefits			$ 0
Cash, FDIC insured amount		$ 250,000

v3.24.1.1.u2

INITIAL PUBLIC OFFERING (Details Narrative) - IPO [Member]	Dec. 19, 2023 $ / shares shares
Subsidiary, Sale of Stock [Line Items]
Stock issued shares new issues | shares	6,000,000
Sale of stock, par share | $ / shares	$ 10.00
Stock holders equity related to initial public offering description	Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights.

v3.24.1.1.u2

PRIVATE PLACEMENTS (Details Narrative) - Private Placement [Member]	Dec. 19, 2023 USD ($) $ / shares shares
Subsidiary, Sale of Stock [Line Items]
Stock issued shares new issues | shares	232,500
Share price | $ / shares	$ 10.00
Proceeds from private placement | $	$ 2,325,000
Stock holders equity related to private placement description	Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination.

v3.24.1.1.u2

RELATED PARTIES (Details Narrative) - USD ($)						2 Months Ended
	Jan. 28, 2024	Dec. 27, 2023	Dec. 14, 2023	Mar. 14, 2023	Feb. 23, 2023	Mar. 31, 2023	Mar. 31, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Proceeds from issuance of common stock						$ 25,100
Number of shares forfeited by sponsors						225,000
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Number of shares forfeited by sponsors	225,000
Related Party [Member]
Related Party Transaction [Line Items]
Due to related party								$ 10,000
Related Party [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Promissory note aggregate principal amount					$ 300,000
Founder Shares [Member] | Investor [Member]
Related Party Transaction [Line Items]
Proceeds from Issuance of Common Stock			$ 100
Founder Shares [Member] | Bayview Holding LP [Member]
Related Party Transaction [Line Items]
Stock issued shares new issues			569,250
Founder Shares [Member] | Peace Investment Holdings Limited [Member]
Related Party Transaction [Line Items]
Stock issued shares new issues			1,155,750
Sponsors [Member]
Related Party Transaction [Line Items]
Stock issued shares new issues				963,125	1,437,500
Proceeds from issuance of common stock					$ 25,000
Payments to related party		$ 100
Sponsors [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Stock issued shares new issues			287,500	963,125

v3.24.1.1.u2

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)			2 Months Ended	3 Months Ended
	Jan. 28, 2024	Dec. 19, 2023	Mar. 31, 2023	Mar. 31, 2024
Subsidiary, Sale of Stock [Line Items]
Number of shares forfeited by sponsors			225,000
Cash underwriting discount per unit		$ 0.20
Cash underwriting discount		$ 1,200,000
Deferred commission per unit				$ 0.35
Deferred commission				$ 2,100,000
Proceeds from stock options exercised				$ 100
Shares exercisable				540,000
Exercise price				$ 11.50
Exercise price percentage				115.00%
Number of options and units, shares				540,000
Number of options and units, ordinary shares				540,000
Number of options and units, rights to purchas ordinary shares				54,000
Business combination related cost				$ 170,000
Business combination contingent consideration , receivables				$ 170,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during the period, shares				900,000
Number of shares forfeited by sponsors	225,000
Stock issued during the period, value		$ 1,380,000

v3.24.1.1.u2

SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)							2 Months Ended	3 Months Ended
	Jan. 28, 2024	Dec. 27, 2023	Dec. 14, 2023	Mar. 31, 2023	Mar. 14, 2023	Feb. 23, 2023	Mar. 31, 2023	Mar. 31, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Preferred stock, shares authorized								2,000,000	2,000,000
Preferred stock, par value								$ 0.0001	$ 0.0001
Preferred stock voting rights								voting and other rights and preferences as may be determined from time to time by the Company’s board of directors
Preferred stock, shares issued								0	0
Preferred stock, shares outstanding								0	0
Ordinary stock, shares authorized								200,000,000	200,000,000
Ordinary stock, par value								$ 0.0001	$ 0.0001
Stock issued value new issues							$ 25,100
Number of shares forfeited by sponsors							225,000
Common stock, shares issued				1,725.00			1,725.00	1,732,500	1,957,500
Common stock, shares outstanding				1,725.00			1,725.00	1,732,500	1,957,500
Shares subject to possible redemption, shares				6,000,000			6,000,000	6,000,000	6,000,000
Rights description								each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.
Over-Allotment Option [Member]
Class of Stock [Line Items]
Number of shares forfeited by sponsors	225,000
Founder Shares [Member] | Investor [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Common Stock			$ 100
Founder Shares [Member] | Bayview Holding LP [Member]
Class of Stock [Line Items]
Stock issued shares new issues			569,250
Founder Shares [Member] | Peace Investment Holdings Limited [Member]
Class of Stock [Line Items]
Stock issued shares new issues			1,155,750
Sponsors [Member]
Class of Stock [Line Items]
Stock issued shares new issues					963,125	1,437,500
Stock issued value new issues						$ 25,000
Payments to related party		$ 100
Ordinary shares subject to forfeiture				225,000
Sponsors [Member] | Founder Shares [Member]
Class of Stock [Line Items]
Stock issued shares new issues			287,500		963,125

v3.24.1.1.u2

SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment held in trust account	$ 60,861,367	$ 60,107,055
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment held in trust account	60,861,367	60,107,055
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment held in trust account
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment held in trust account

---